AHR and neoplasm: We suggest that these two factors might be direct targets for miR-494 and that both AHR and ELF-1 can bind to the TFPI2 5′-flanking region, thereby influencing the expression of TFPI2 and thereby contribute to the tumor suppressor role of miR-494 in breast cancer.